PERCUTANEOUS-ABSORPTION ENHANCEMENT OF LEUPROLIDE

被引:34
作者
LU, MYF
LEE, D
RAO, GS
机构
[1] Pharmaceutical Products Division, Abbott Laboratories, North Chicago, Illinois
关键词
LEUPROLIDE; PERCUTANEOUS ABSORPTION; HUMAN SKIN; SNAKE SKIN; MOUSE SKIN; MENTHOL; CAMPHOR; METHYL SALICYLATE; UREA; SKIN IRRITATION;
D O I
10.1023/A:1015860324161
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chemical enhancers and vehicles were tested for their ability to improve the percutaneous absorption of leuprolide, a nonapeptide (luteinizing hormone releasing hormone analogue; MW 1209.4). In vitro permeabilities in nude mouse, snake, and cadaver skin were evaluated in either Franz diffusion cells or a Bronaugh flow-through system using an HPLC assay. Skin irritation caused by the formulations was evaluated in the rabbit. The chemical enhancer systems investigated strongly enhanced skin penetration of leuprolide. Maximum permeability enhancement of leuprolide acetate can be achieved with a nonirritating formulation containing ethanol, menthol, camphor, methyl salicylate, urea, and hydrogel. The in vitro permeability in nude mouse skin was 10 or 100 times higher than that obtained in cadaver skin, depending on the type of enhancer that was used in the formulation. Snake skin was at least 10 times less permeable than cadaver skin in this study. However, the effects of chemical enhancers on skin permeability were highly dependent on the skin model. Further, the in vitro permeability of leuprolide in the base form was 10 times higher than in the acetate form with the enhancers.
引用
收藏
页码:1575 / 1579
页数:5
相关论文
共 21 条
[1]   BIOAVAILABILITY OF LEUPROLIDE FOLLOWING INTRATRACHEAL ADMINISTRATION TO BEAGLE DOGS [J].
ADJEI, A ;
DOYLE, R ;
PRATT, M ;
FINLEY, R ;
JOHNSON, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 61 (1-2) :135-144
[2]   SKIN PERMEABILITY IN-VIVO - COMPARISON IN RAT, RABBIT, PIG AND MAN [J].
BARTEK, MJ ;
LABUDDE, JA ;
MAIBACH, HI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1972, 58 (03) :114-&
[3]   METHODS FOR INVITRO PERCUTANEOUS-ABSORPTION STUDIES .7. USE OF EXCISED HUMAN-SKIN [J].
BRONAUGH, RL ;
STEWART, RF ;
SIMON, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (11) :1094-1097
[4]   ABSORPTION AND METABOLISM OF NAFARELIN, A POTENT AGONIST OF GONADOTROPIN-RELEASING HORMONE [J].
CHAN, RL ;
HENZL, MR ;
LEPAGE, ME ;
LAFARGUE, J ;
NERENBERG, CA ;
ANIK, S ;
CHAPLIN, MD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (03) :275-282
[5]  
FISHER AA, 1984, CUTIS, V34, P526
[6]  
GHANEM A-H, 1987, Journal of Controlled Release, V6, P75, DOI 10.1016/0168-3659(87)90065-4
[7]  
GRICE K, 1973, ACTA DERM-VENEREOL, V53, P114
[8]   ADVERSE DERMATOLOGICAL REACTIONS TO TRANSDERMAL DRUG DELIVERY SYSTEMS [J].
HOGAN, DJ ;
MAIBACH, HI .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 22 (05) :811-814
[9]   USE OF SHED SNAKE SKIN AS A MODEL MEMBRANE FOR INVITRO PERCUTANEOUS PENETRATION STUDIES - COMPARISON WITH HUMAN SKIN [J].
ITOH, T ;
XIA, J ;
MAGAVI, R ;
NISHIHATA, T ;
RYTTING, JH .
PHARMACEUTICAL RESEARCH, 1990, 7 (10) :1042-1047
[10]   THOUGHTS ON IRRITANT CONTACT-DERMATITIS [J].
MALTEN, KE .
CONTACT DERMATITIS, 1981, 7 (05) :238-247